Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP2R2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RPS6KA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM200B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SSX2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP85 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MERTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGT2B15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC121 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMBIM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AQP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on